AI tool gains Class IIB regulatory approval in UK first
Posted:
Sanome has secured Class IIb CE certification and MHRA approval for MEMORI - an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs).
Alzheimer’s disease is the most common cause of dementia, responsible for up to 80% of dementia cases worldwide.
In a mouse model, KCL-286, a drug that has passed phase 1 trials for spinal injuries in people, repaired DNA breaks and…
Neko Health has raised US$700m to fund its first US expansion, new clinics and further development of its preventative health tech.
The Series C round follows a US$260m Series B in January 2025.
Founded by Spotify’s Daniel Ek and Hjalmar…
Attendees
Sponsors and Exhibitors
Contact us